First, the most important of the three
two — in Cain v. Hassan, et al., the putative shareholders’ derivative suit, the newly-extended due date for motions in response to Schering’s motion to dismiss the action is September 22 2, 2008 — by agreement of the parties. Defendants’ replies will then be due by October 15, 2008.
Second, but falling earlier on the calendar — for those keep score at home — is in the Clarinex® patent litigation, captioned In Re Descloratadine Patent Litigation (litigation in which Schering is the plaintiff), Orchid Pharmaceuticals’ (the Defendant’s) written answers, or other responsive pleadings — to Schering’s Complaint, will now be due — on August 6, 2008 — again, by agreement of the parties.
Finally, in the putative Securities Class Action — Schering-Plough ENHANCE Litigation, Mason v. Schering-Plough, et al., (Case No. 08-397) the Lead Plaintiffs now have until September 15, 2008 to file an amended, Consolidated Complaint — yes, again, by agreement of the parties.
Each of these matters is now pending in the federal district courts in Newark, New Jersey.